
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of KI-67 positive cellular index on prognosis after hepatectomy in Barcelona Clinic Liver Cancer stage A and B hepatocellular carcinoma with microvascular invasion
Honghao Li, Lu‐Nan Qi, Liang Ma, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 4747-4754
Open Access | Times Cited: 36
Honghao Li, Lu‐Nan Qi, Liang Ma, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 4747-4754
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Homogenous multifunctional microspheres induce ferroptosis to promote the anti-hepatocarcinoma effect of chemoembolization
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Minjiang Chen, Jie Li, Gaofeng Shu, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Texture analysis of multi-phase MRI images to detect expression of Ki67 in hepatocellular carcinoma
Yueming Li, Chuan Yan, Shuping Weng, et al.
Clinical Radiology (2019) Vol. 74, Iss. 10, pp. 813.e19-813.e27
Closed Access | Times Cited: 38
Yueming Li, Chuan Yan, Shuping Weng, et al.
Clinical Radiology (2019) Vol. 74, Iss. 10, pp. 813.e19-813.e27
Closed Access | Times Cited: 38
Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma
Xihua Yang, Hang-Hang Ni, Lu Zhan, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Xihua Yang, Hang-Hang Ni, Lu Zhan, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Imaging‐Based Prediction of Ki‐67 Expression in Hepatocellular Carcinoma: A Retrospective Study
Chiyu Cai, Liancai Wang, Lianyuan Tao, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Chiyu Cai, Liancai Wang, Lianyuan Tao, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
Three-dimensional MR elastography-based stiffness for assessing the status of Ki67 proliferation index and Cytokeratin-19 in hepatocellular carcinoma
Lina Zhang, Yuanqiang Xiao, Mengshi Dong, et al.
European Radiology (2025)
Closed Access
Lina Zhang, Yuanqiang Xiao, Mengshi Dong, et al.
European Radiology (2025)
Closed Access
Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma
Hongxiang Li, Jing Zhang, Baoer Liu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Hongxiang Li, Jing Zhang, Baoer Liu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Prediction of Ki-67 expression in hepatocellular carcinoma with machine learning models based on intratumoral and peritumoral radiomic features
Ziwei Zhu, Junhua Wu, Yang Guo, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 5
Open Access
Ziwei Zhu, Junhua Wu, Yang Guo, et al.
World Journal of Gastrointestinal Oncology (2025) Vol. 17, Iss. 5
Open Access
Evaluation of the Therapeutic Effect of Adjuvant Transcatheter Arterial Chemoembolization Based on Ki67 After Hepatocellular Carcinoma Surgery
Yufei Zhao, Xiu Xiong, Kai Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Yufei Zhao, Xiu Xiong, Kai Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
Nomogram development and validation to predict Ki-67 expression of hepatocellular carcinoma derived from Gd-EOB-DTPA-enhanced MRI combined with T1 mapping
Ziwei Liu, Shaomin Yang, Xinjie Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Ziwei Liu, Shaomin Yang, Xinjie Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Hepatocellular Carcinoma ≤5 cm: Biological Characteristics and Patient Outcomes
Wenjia Cai, Minghua Ying, Rongqin Zheng, et al.
Liver Cancer (2023) Vol. 12, Iss. 4, pp. 356-371
Open Access | Times Cited: 7
Wenjia Cai, Minghua Ying, Rongqin Zheng, et al.
Liver Cancer (2023) Vol. 12, Iss. 4, pp. 356-371
Open Access | Times Cited: 7
A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma
Yingying Liang, Fan Xu, Qiuju Mou, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Yingying Liang, Fan Xu, Qiuju Mou, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma
Mengqi Huang, Fan Zhang, Zhen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Mengqi Huang, Fan Zhang, Zhen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
MRI Radiomics Combined with Clinicopathological Factors for Predicting 3-Year Overall Survival of Hepatocellular Carcinoma After Hepatectomy
Fangyuan Kuang, Yang Gao, Qingyun Zhou, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1445-1457
Open Access | Times Cited: 2
Fangyuan Kuang, Yang Gao, Qingyun Zhou, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1445-1457
Open Access | Times Cited: 2
Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways
Omar A. Ammar, Mohamed A. El‐Missiry, Azza I. Othman, et al.
Heliyon (2022) Vol. 8, Iss. 1, pp. e08837-e08837
Open Access | Times Cited: 10
Omar A. Ammar, Mohamed A. El‐Missiry, Azza I. Othman, et al.
Heliyon (2022) Vol. 8, Iss. 1, pp. e08837-e08837
Open Access | Times Cited: 10
Diffusion-Weighted Imaging as a Quantitative Imaging Biomarker for Predicting Proliferation Rate in Hepatocellular Carcinoma: Developing a Radiomics Nomogram
Chuan Yan, Zewen Han, Xiaojie Chen, et al.
Journal of Computer Assisted Tomography (2023) Vol. 47, Iss. 4, pp. 539-547
Open Access | Times Cited: 5
Chuan Yan, Zewen Han, Xiaojie Chen, et al.
Journal of Computer Assisted Tomography (2023) Vol. 47, Iss. 4, pp. 539-547
Open Access | Times Cited: 5
Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma
Yan Yang, Xiao Shi Lin, Ming Wang, et al.
Academic Radiology (2023) Vol. 31, Iss. 3, pp. 859-869
Closed Access | Times Cited: 5
Yan Yang, Xiao Shi Lin, Ming Wang, et al.
Academic Radiology (2023) Vol. 31, Iss. 3, pp. 859-869
Closed Access | Times Cited: 5
Preoperative prediction of hepatocellular carcinoma with highly aggressive characteristics using quantitative parameters derived from hepatobiliary phase MR images
Zheng Ye, Likun Cao, Yi Wei, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 4, pp. 85-85
Open Access | Times Cited: 14
Zheng Ye, Likun Cao, Yi Wei, et al.
Annals of Translational Medicine (2020) Vol. 8, Iss. 4, pp. 85-85
Open Access | Times Cited: 14
Toll‐like receptor 5 and 8 in hepatocellular carcinoma
Valtteri Kairaluoma, Niko Kemi, Heikki Huhta, et al.
Apmis (2021) Vol. 129, Iss. 8, pp. 470-479
Open Access | Times Cited: 12
Valtteri Kairaluoma, Niko Kemi, Heikki Huhta, et al.
Apmis (2021) Vol. 129, Iss. 8, pp. 470-479
Open Access | Times Cited: 12
Graphene oxide nanofilm and chicken embryo extract decrease the invasiveness of HepG2 liver cancer cells
Malwina Sosnowska, Marta Kutwin, Barbara Strojny, et al.
Cancer Nanotechnology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Malwina Sosnowska, Marta Kutwin, Barbara Strojny, et al.
Cancer Nanotechnology (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation
Wanjing Zheng, Xiaodan Chen, Meilian Xiong, et al.
Journal of Magnetic Resonance Imaging (2024) Vol. 60, Iss. 6, pp. 2643-2654
Open Access | Times Cited: 1
Wanjing Zheng, Xiaodan Chen, Meilian Xiong, et al.
Journal of Magnetic Resonance Imaging (2024) Vol. 60, Iss. 6, pp. 2643-2654
Open Access | Times Cited: 1
iTRAQ‑based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells
Yanan Xu, Xian Li, Xiulan Su
Oncology Reports (2019)
Open Access | Times Cited: 9
Yanan Xu, Xian Li, Xiulan Su
Oncology Reports (2019)
Open Access | Times Cited: 9
The Benefit of Apparent Diffusion Coefficient in Evaluating the Invasiveness of Hepatocellular Carcinoma
Mengyuan Jing, Yuntai Cao, Peng Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Mengyuan Jing, Yuntai Cao, Peng Zhang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 8
Added value of CE-CT radiomics to predict high Ki-67 expression in hepatocellular carcinoma
Yu‐Meng Zhao, Shuang-Shuang Xie, Jian Wang, et al.
BMC Medical Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Yu‐Meng Zhao, Shuang-Shuang Xie, Jian Wang, et al.
BMC Medical Imaging (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Pathological prognostic factors for post-resection survival in patients with hepatocellular carcinoma associated with non-alcoholic fatty liver disease
Mizelle D’Silva, Hee Young Na, Jai Young Cho, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 7, pp. 3345-3355
Open Access | Times Cited: 4
Mizelle D’Silva, Hee Young Na, Jai Young Cho, et al.
Translational Cancer Research (2021) Vol. 10, Iss. 7, pp. 3345-3355
Open Access | Times Cited: 4
Outcomes of postoperative adjuvant transarterial chemoembolization for hepatocellular carcinoma according to the Ki67 index
Jing‐Xuan Xu, Wan-Ting Xing, Yuchong Peng, et al.
Future Oncology (2022) Vol. 18, Iss. 17, pp. 2113-2125
Closed Access | Times Cited: 3
Jing‐Xuan Xu, Wan-Ting Xing, Yuchong Peng, et al.
Future Oncology (2022) Vol. 18, Iss. 17, pp. 2113-2125
Closed Access | Times Cited: 3